Category : Digestive Health

The fact some people respond to a drug treatment while for others the same treatment is totally ineffective may depend on our gut microbiota. In other words, after a drug is administered orally, it could either be absorbed into the bloodstream and metabolized by the liver, or it remains in the intestine where it can be metabolized by the gut…

GMFH Editing Team
GMFH Editing Team

The fact some people respond to a drug treatment while for others the same treatment is totally ineffective may depend on our gut microbiota. In other words, after a drug is administered orally, it could either be absorbed into the bloodstream and metabolized by the liver, or it remains in the intestine where it can be metabolized by the gut…

GMFH Editing Team
GMFH Editing Team

Imbalances in the small intestinal microbiome can drive clinical consequences in the form of small intestinal bacterial overgrowth (SIBO), characterized by higher numbers of bacteria and a distribution more commonly associated with the colon. In recent times, SIBO has been recognized as a frequent cause of common gastrointestinal conditions that share risk factors such as maldigestion and malabsorption. Methods used…

GMFH Editing Team
GMFH Editing Team

Imbalances in the small intestinal microbiome can drive clinical consequences in the form of small intestinal bacterial overgrowth (SIBO), characterized by higher numbers of bacteria and a distribution more commonly associated with the colon. In recent times, SIBO has been recognized as a frequent cause of common gastrointestinal conditions that share risk factors such as maldigestion and malabsorption. Methods used…

GMFH Editing Team
GMFH Editing Team

The functional metagenomic screening of the human gut microbiome gives us a better understanding of how microbial genes shape almost all aspects of physiology. Although an important number of microbial species have yet to be characterized, next generation approaches have increased the number of gut microorganism genomes that can be mapped. For instance, analysis of the gut metagenome has provided…

GMFH Editing Team
GMFH Editing Team

The functional metagenomic screening of the human gut microbiome gives us a better understanding of how microbial genes shape almost all aspects of physiology. Although an important number of microbial species have yet to be characterized, next generation approaches have increased the number of gut microorganism genomes that can be mapped. For instance, analysis of the gut metagenome has provided…

GMFH Editing Team
GMFH Editing Team

The gut microbiota has become a new player in the onset and development of metabolic syndrome and its associated pathologies. One gut bacterium that has been positively associated with leanness in mice and humans is Akkermansia muciniphila, which is naturally present in the gut microbiota of healthy people. In 2017, our research team at UCLouvain (Belgium) found that a pasteurized…

Patrice D. Cani
Professor Patrice D. Cani is researcher from the Belgian Fund for Scientific Research (FRS-FNRS), group leader in the Metabolism and Nutrition research group at the Louvain Drug Research Institute (LDRI) from the Université catholique de Louvain (UCL), Brussels, Belgium, and WELBIO (Walloon Excellence in Lifesciences and BIOtechnology) investigator. He is currently member of several international associations, he is member of the Alumni College from the Royal Belgian Academy of Sciences, and he has been elected in the board of directors of the LDRI (UCL). Patrice D. Cani has a M.Sc. in Nutrition and another M.Sc. in health Sciences, he is registered dietitian and PhD in Biomedical Sciences. His main research interests are the investigation of the role of the gut microbiota in the development of metabolic disorders, such as obesity, type 2 diabetes and low grade inflammation. More specifically, he is investigating the interactions between the gut microbiota, the host and specific biological systems such as the endocannabinoid system and the innate immune system in the context of obesity, type 2 diabetes and metabolic inflammation. Prof Cani is author and co-author of more than 110 scientific research papers published in peer-reviewed international journals, conferences and book chapters.

The gut microbiota has become a new player in the onset and development of metabolic syndrome and its associated pathologies. One gut bacterium that has been positively associated with leanness in mice and humans is Akkermansia muciniphila, which is naturally present in the gut microbiota of healthy people. In 2017, our research team at UCLouvain (Belgium) found that a pasteurized…

Patrice D. Cani
Professor Patrice D. Cani is researcher from the Belgian Fund for Scientific Research (FRS-FNRS), group leader in the Metabolism and Nutrition research group at the Louvain Drug Research Institute (LDRI) from the Université catholique de Louvain (UCL), Brussels, Belgium, and WELBIO (Walloon Excellence in Lifesciences and BIOtechnology) investigator. He is currently member of several international associations, he is member of the Alumni College from the Royal Belgian Academy of Sciences, and he has been elected in the board of directors of the LDRI (UCL). Patrice D. Cani has a M.Sc. in Nutrition and another M.Sc. in health Sciences, he is registered dietitian and PhD in Biomedical Sciences. His main research interests are the investigation of the role of the gut microbiota in the development of metabolic disorders, such as obesity, type 2 diabetes and low grade inflammation. More specifically, he is investigating the interactions between the gut microbiota, the host and specific biological systems such as the endocannabinoid system and the innate immune system in the context of obesity, type 2 diabetes and metabolic inflammation. Prof Cani is author and co-author of more than 110 scientific research papers published in peer-reviewed international journals, conferences and book chapters.

The enteric nervous system (ENS)—also called “our second brain”—is an autonomous part of the nervous system consisting of in the myenteric and submucosal plexus within the wall of the gastrointestinal tract. Comprising primary afferent neurons, interneurons and motor neurons, alongside intestinal cells involved in immune responses and endocrine and paracrine functions, it is involved in the sensory-motor control of the…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

The enteric nervous system (ENS)—also called “our second brain”—is an autonomous part of the nervous system consisting of in the myenteric and submucosal plexus within the wall of the gastrointestinal tract. Comprising primary afferent neurons, interneurons and motor neurons, alongside intestinal cells involved in immune responses and endocrine and paracrine functions, it is involved in the sensory-motor control of the…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

A current challenge in gut microbiome science is that of characterizing the effects of food groups on gut microbial communities instead of focusing on isolated nutrients. Although prebiotics provide health benefits by specifically altering the composition or activity of the gut microbiota, not all dietary fibers are prebiotics and they can benefit gut bacterial groups in different ways. A new…

GMFH Editing Team
GMFH Editing Team

A current challenge in gut microbiome science is that of characterizing the effects of food groups on gut microbial communities instead of focusing on isolated nutrients. Although prebiotics provide health benefits by specifically altering the composition or activity of the gut microbiota, not all dietary fibers are prebiotics and they can benefit gut bacterial groups in different ways. A new…

GMFH Editing Team
GMFH Editing Team

Specific dietary modifications have been an area of focus to treat a myriad of diseases such as obesity and IBS. However, the individual response to dietary interventions can vary greatly, partly due to our unique gut microbiota compositions. Personalized nutrition is a promising area of research that aims to predict physiological response to dietary interventions based on a person's gut microbial…

Allison Clark
Allison Clark has a master in nutrition and health from Open University in Barcelona and a master in journalism. She is a freelance writer and nutritionist and has written various peer review papers about the role the gut microbiota plays in health, disease and endurance exercise performance. Allison is passionate about the role diet and the gut microbiota play in health and disease. Follow her on Twitter @Heal_your_Gut

Specific dietary modifications have been an area of focus to treat a myriad of diseases such as obesity and IBS. However, the individual response to dietary interventions can vary greatly, partly due to our unique gut microbiota compositions. Personalized nutrition is a promising area of research that aims to predict physiological response to dietary interventions based on a person's gut microbial…

Allison Clark
Allison Clark has a master in nutrition and health from Open University in Barcelona and a master in journalism. She is a freelance writer and nutritionist and has written various peer review papers about the role the gut microbiota plays in health, disease and endurance exercise performance. Allison is passionate about the role diet and the gut microbiota play in health and disease. Follow her on Twitter @Heal_your_Gut

Recurrence of inflammatory lesions is frequent in patients undergoing ileal resection for Crohn’s disease (CD). Although male gender, active smoking at surgery and previous intestinal resection have all been associated with a higher risk of endoscopic post-operative recurrence—as assessed by ileocolonoscopy—there is not a single clinical risk factor that can be used as a perfect predictor of early postoperative endoscopic…

GMFH Editing Team
GMFH Editing Team

Recurrence of inflammatory lesions is frequent in patients undergoing ileal resection for Crohn’s disease (CD). Although male gender, active smoking at surgery and previous intestinal resection have all been associated with a higher risk of endoscopic post-operative recurrence—as assessed by ileocolonoscopy—there is not a single clinical risk factor that can be used as a perfect predictor of early postoperative endoscopic…

GMFH Editing Team
GMFH Editing Team

Over 350 physicians, dietitians, nutritionists, advanced practice providers and researchers from 49 countries gathered in Miami (USA), on March 23-24, for the 8th edition of the Gut Microbiota for Health World Summit 2019, where world-renowned experts in the field discussed the latest evidence on the interaction between diet, nutrition and the gut microbiome. With Gail Hecht and Francisco Guarner as…

GMFH Editing Team
GMFH Editing Team

Over 350 physicians, dietitians, nutritionists, advanced practice providers and researchers from 49 countries gathered in Miami (USA), on March 23-24, for the 8th edition of the Gut Microbiota for Health World Summit 2019, where world-renowned experts in the field discussed the latest evidence on the interaction between diet, nutrition and the gut microbiome. With Gail Hecht and Francisco Guarner as…

GMFH Editing Team
GMFH Editing Team

From hunter-gathering to industrialization, our gut microbiome has adapted and evolved under environmental pressures. The current period of modernization is seeing changes in dietary patterns and medical practices that have driven a deterioration of gut microbial communities over generations. And this, in turn, contributes to explaining the current rise in chronic diseases in industrialized societies. A new opinion article from…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

From hunter-gathering to industrialization, our gut microbiome has adapted and evolved under environmental pressures. The current period of modernization is seeing changes in dietary patterns and medical practices that have driven a deterioration of gut microbial communities over generations. And this, in turn, contributes to explaining the current rise in chronic diseases in industrialized societies. A new opinion article from…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados